![](/img/cover-not-exists.png)
Treatment of minimal residual disease in poor risk acute lymphoblastic leukaemia with high-dose cytosine arabinoside (ARA-C)
M.J. Barnett, J.E. Kingston, A. Miller, L.K. Goff, T.S. Ganesan, R. Biruls, A.Z.S. Rohatiner, J.S. Malpas, T.A. ListerVolume:
10
Year:
1986
Language:
english
DOI:
10.1016/0145-2126(86)90131-1
File:
PDF, 93 KB
english, 1986